Integra LifeSciences Holdings Corporation (IART) 追踪市盈率为负值 -1.4, 表示公司目前在过去十二个月 (TTM) 基础上处于亏损状态。 前瞻市盈率 4.7 基于分析师预估，预计将恢复盈利。 追踪盈利收益率为 -72.01%, 前瞻盈利收益率 21.23%. PEG 0.61 (Peter Lynch 低估标准 ≤1.0).
本页证实的标准:
SharesGrow 综合评分： 46/100 其中 1/7 项标准通过。
| Year | P/E (TTM) | PEG 比率 | P/B 比率 | P/S 比率 | 股息收益率 |
|---|---|---|---|---|---|
| 2016 | 43.0 | -0.02 | 3.82 | 3.23 | - |
| 2017 | 58.0 | -3.41 | 3.90 | 3.16 | - |
| 2018 | 61.5 | -5.10 | 2.72 | 2.54 | - |
| 2019 | 99.4 | -5.18 | 3.52 | 3.29 | - |
| 2020 | 41.0 | 0.24 | 3.63 | 4.01 | - |
| 2021 | 33.6 | 1.26 | 3.37 | 3.68 | - |
| 2022 | 25.8 | 2.86 | 2.58 | 2.99 | - |
| 2023 | 50.3 | -0.84 | 2.14 | 2.21 | - |
| 2024 | -251.5 | 2.28 | 1.13 | 1.08 | - |
| 2025 | -1.8 | 0.00 | 0.91 | 0.58 | - |
| Year | EPS（稀释） | 营收 | 净利润 | 净利润率 |
|---|---|---|---|---|
| 2016 | $0.94 | $992.08M | $74.56M | 7.5% |
| 2017 | $0.82 | $1.19B | $64.74M | 5.4% |
| 2018 | $0.72 | $1.47B | $60.8M | 4.1% |
| 2019 | $0.58 | $1.52B | $50.2M | 3.3% |
| 2020 | $1.57 | $1.37B | $133.89M | 9.8% |
| 2021 | $1.98 | $1.54B | $169.08M | 11% |
| 2022 | $2.16 | $1.56B | $180.55M | 11.6% |
| 2023 | $0.84 | $1.54B | $67.74M | 4.4% |
| 2024 | $-0.09 | $1.61B | $-6.94M | -0.4% |
| 2025 | $-6.73 | $1.64B | $-516.47M | -31.6% |
| Year | EPS（平均） | EPS 范围 | 营收（平均） | 营收范围 | 分析师人数 |
|---|---|---|---|---|---|
| 2026 | $2.35 | $2.30 – $2.37 | $1.67B | $1.65B – $1.68B | 6 |
| 2027 | $2.56 | $2.52 – $2.60 | $1.73B | $1.72B – $1.74B | 4 |
| 2028 | $2.72 | $2.70 – $2.75 | $1.78B | $1.78B – $1.78B | 1 |
